Pharmaceutical and life sciences

Helping clients better compete in an evolving health market and improve cost-efficiency and profitability.

Top industry issues – video perspectives from our leaders

In this video series, PwC's Pharmaceutical and Life Sciences leaders help you navigate through top issues and offer practical guidance on your most pressing sector challenges. Our PLS practice helps organizations – from those who develop drugs, to those who manufacture medical devices – connect to consumer needs and develop and deliver tomorrow's treatments. We deliver effective solutions to the complex strategic, operational, and financial challenges facing our industry.

See more

loading-player

Playback of this video is not currently available

The potential impact of tax reform on pharmaceutical and life sciences companies 

From President Trump's tax plan to health care reform - we break down developments from Washington and what companies in our industry need to do to anticipate and prepare for legislative change.

Learn more

{{filterContent.facetedTitle}}

Contact us

Karen C. Young
US Pharmaceutical and Life Sciences Leader, PwC US
Tel: +1 (973) 236 5648
Email

Michael Swanick
Global Pharmaceutical and Life Sciences Leader, PwC US
Tel: +1 (267) 330 6060
Email

Kathleen Michael
US Health Industries Tax Leader, PwC US
Tel: +1 (973) 236 4210
Email

Douglas Strang
Global Pharmaceutical and Life Sciences Advisory Leader, PwC US
Tel: +1 (267) 330 3045
Email

Rick Edmunds
Principal, Strategy&, PwC US
Tel: +1 (703) 682 5755
Email

Glenn Hunzinger
US Pharmaceutical and Life Sciences Deals Leader, PwC US
Tel: +1 (646) 818 7742
Email

Laura Robinette
US Pharmaceutical and Life Sciences Assurance Leader, PwC US
Tel: +1 (919) 791 4100
Email

Craig Cleaver
US Pharmaceutical and Life Sciences Risk Assurance Leader, PwC US
Tel: +1 (267) 330 2908
Email

Follow us